newsfilter
← Latest News
PR Newswire·

Tryp Therapeutics Announces Q1 2022 Financial Results

SAN DIEGO, Jan. 28, 2022 /PRNewswire/ -- Tryp Therapeutics (CSE:TRYP) (OTCQB:TRYPF) ("Tryp" or the "Company"), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, announced today its interim f